Clinogent

Established in 2003, Clinogent is the Clinical Research & Development business unit of GVK BIO. A full service CRO, Clinogent offers a suite of Clinical Pharmacology and Clinical Research services to support Innovator & Generic Pharmaceutical and Biotech organizations globally. Clinogent is an internationally reputed service provider and has one of the largest state-of-the-art facilities in India inspected by DCGI, USFDA, ANSM, WHO, MHRA, ANVISA & MoH Turkey, thereby crediting it with global submission footprint. Housed in a lab space of 140,000 sq.ft, Clinogent has seven independent clinics with 254 beds. Clinogent hosts a scientific pool of 300 scientists, Senior Leadership team with around 15 – 20 years in Clinical development, >275 clinical investigators and over 35000 volunteer databases. Clinogent has successfully handled 1000+ bio studies and >350,000 bio-analytical samples per year. Clinogent is a preferred partner of the Bill & Melinda Gates Foundation and CSIR for Clinical Research Services. It has the distinction of being a CRO with the most extensive Vaccines experience in India (17 trials-India and Bangladesh). Currently the team have worked on 80+ projects across >14 therapeutic areas in the last 10 years, having monitoring sites across India, Bangladesh and Nepal.